{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:20:48Z","timestamp":1795022448067,"version":"4.10.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Cases of acute myeloid leukemia occurring simultaneously with multiple myelomas are rare. To date, only 31 cases have been reported worldwide. The prognosis of these patients is very poor, and it is very important for them to be diagnosed promptly and treated effectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 68-year-old male patient was admitted due to the presence of intermittent nosebleeds accompanied by fever for 10 days, in addition to the development of a right neck mass over 3 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Diagnosis of acute monocytic leukemia (high-risk group) was based on morphology, immunophenotyping, histochemical staining, and chromosomal and genetic test results. The patient\u2019s chromosomes were found to be normal, yet next-generation sequencing revealed a TP53 mutation, thus classifying the risk stratification as high risk. The diagnosis of multiple myeloma was diagnosed based on the presence of\u2005&gt;\u200510% myeloma cells and bone marrow biopsy findings suggestive of multiple myeloma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Azacitidine 100\u2009mg subcutaneous injection on days 1 to 7, in conjunction with hydrocortisone 50\u2009mg every 12 hours, to treat acute myeloid leukemia in conjunction with multiple myeloma. During this course of treatment, the patient was administered anti-infectious therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient developed a brain abscess during treatment and passed away 2 months after hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The patient\u2019s disease was severe and rapidly progressive, and comorbid severe infections and consistent comorbid severe pancytopenia posed challenges in managing this disease. It is hoped that more effective targeted therapies can be explored for such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045190","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:02:14Z","timestamp":1761332534000},"page":"e45190","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A case of acute myeloid leukemia and multiple myeloma is observed to occur simultaneously"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4487-2997","authenticated-orcid":false,"given":"Shanfeng","family":"Hao","sequence":"first","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Characteristic Medical Center of Chinese People\u2019s Armed Police Force, Tianjin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-2717","authenticated-orcid":false,"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2013-07-515999","article-title":"Simultaneous presentation of plasma cell myeloma and acute promyelocytic leukemia.","volume":"122","author":"Schafernak","year":"2013","journal-title":"Blood"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0042-1757588","article-title":"Twin malignancy of acute myeloid leukemia and multiple myeloma in a chemotherapy-naive patient: a rare occurrence.","volume":"15","author":"Jamal","year":"2023","journal-title":"J Lab Physicians"},{"key":"R7-20261118","first-page":"869","article-title":"[Acute myeloid leukemia (M(3)) with multiple myeloma: a case report].","volume":"44","author":"Yan","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R8-20261118","first-page":"553","article-title":"Effective treatment with venetoclax and hypomethylating agents for the coexistence of multiple myeloma and acute myeloid leukemia: a case report and literature review.","volume":"54","author":"Chen","year":"2024","journal-title":"Ann Clin Lab Sci"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergen.2023.12.005","article-title":"Simultaneous occurrence of multiple myeloma and acute myeloid leukemia: case report and literature review.","volume":"282-283","author":"Li","year":"2024","journal-title":"Cancer Genet"},{"key":"R10-20261118","first-page":"181","article-title":"Venetoclax combined with azacitidine in the treatment of acute myeloid leukemia complicated with multiple myeloma: a case report and literature review.","volume":"32","author":"Yongping","year":"2023","journal-title":"Leuk\u00b7Lymphoma"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1078155220932352","article-title":"Synchronous detection of multiple myeloma and acute myeloid leukemia: a diagnostic and therapeutic challenge.","volume":"27","author":"Maral","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"12431","DOI":"10.21037\/apm-21-3210","article-title":"Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review.","volume":"10","author":"Yan","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1007\/s00277-024-05892-9","article-title":"The clinical efficacy of a daratumumab-based regimen in relapsed\/refractory acute leukemia: a single-center experience.","volume":"103","author":"Dai","year":"2024","journal-title":"Ann Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:02:16Z","timestamp":1795021336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":13,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045190","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2024-11-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}